强直性脊柱炎实验室诊断的研究进展

www.yongyao.net　　2009-8-21 11:03:22　　来源：　　责任编辑：

分享到：

参考文献
[ 1 ] 　Davia JC J r, Huang F,MaksymowychW. New therap ies for ankylosing spondylitis: etanercep t, thaildomide and pamidronate [ J ].Rhuem Dis Clin North Am, 2003, 29 (3) : 4812494.
[ 2 ] 　Davis JC J r. Understanding the role of tumor necrosis factor inhibition in ankylosing spondylitis[ J ]. Semin Arthritis Rheum, 2005, 34(4) : 6682677.
[ 3 ] 　Braun J,Baraliakos X, Brandt J, et al. Persistent clinical response to the anti2TNF2alpha antibody infliximab in patients with ankylosing spondylitis over 3 years[ J ]. Rheumatology, 2005, 44 (5) : 6702676.
[ 4 ] 　Brandt J,Listing J, Haibel H, et al. Long2term efficacy and safety of etanercep t after readministration in patients with active ankylosing spondylitis[ J ]. Rheumatology (Oxford) , 2005, 44 (3) : 3422348.
[ 5 ] 　李天旺,古洁若,梁敏坚,等. 强直性脊柱炎与其他腰痛及关节痛患者人类白细胞抗原2B27磁珠酶联免疫分析的可靠性探讨[ J ]. 中国临床康复, 2005, 23 (9) : 2222223.
[ 6 ] 　Softentino R, Tosi R. HLA2B27 subtype: ankylosing spondylitis association versus pep tide binding specificity HLA2B27 [ J ]. DerSpondyloarthropathies, 1997, 127: 135.
[ 7 ] 　Liu Y,Li J, Chen B, et al. Familial aggregation ankylosing of spondylitis in Southern China [ J ]. J Rheumatol, 2001, 28 ( 3 ) :5502553.
[ 8 ] 　Wei JCC, TsaiWC, Lin HS, et al. HLA2B60 and B61 are strongly associated with ankylosing spondylitis in HLA2B272negative Taiwan Chinese patients [ J ]. Rheumatology (Oxford ) , 2004, 43 ( 7 ) :8392842.
[ 9 ] 　Merino E,Montserrat V, Paradela A, et al. Two HLA2B14 subtypes (B3 1402 and B3 1403) differentially associated with ankylosing spondylitis differ substantially in pep tide specificity but have limited pep tide and T2cell ep itope sharing with HLA2B27 [ J ]. J BiolChem, 2005, 280 (43) : 35868235880.
[ 10 ] 　DrouartM, Saas P,BillotM, et al. High serum vascular endothelial growth factor correlateswith disease activity of spondylarthropathies[ J ]. Clin Exp Immunol, 2003, 132 (1) : 1582162.
[ 11 ] 　Liu OH,Wu OM, Teng Y, et al. Hypothetic verification of the correlation between polymorphism in the p romoter region2308 of the tumor necrosis factor gene and ankylosing spondylitis [ J ]. Chin J
Clin Reh, 2004, 8 (27) : 597425976.
[ 12 ] 　RudwaleitM, Siegerta S, Yinb Z, et al. Low T cell p roduction of TNF and IFN in ankylosing spondylitis: its relation to HLA2B27 and influence of the TNF2308 gene polymorphism [ J ]. Ann Rheum
Dis, 2001, 60 (1) : 36242.
[ 13 ] 　Shadidi KR, Aarvak T, Henriksen JE, et al. The chemokinesCCL5, CCL2 and CXCL12 p lay significant roles in the migration ofThl cells into rheumatoid synovial tissue [ J ]. Scand J Immunol,
2003, 57 (2) : 1922198.
[ 14 ] 　Duftner C,Dejaco C, Kullich W, et al. Preferential type 1 chemokine recep tors and cytokine p roduction of cd282 T2cells in ankylosing spondylitis[ J ]. Ann Rheum Dis, 2006, 65 (5) : 6472653.
[ 15 ] 　Punzi L, Calo L, PlebaniM. Clinical significance of cytokine determination in synovial fluid [ J ]. Grit Rev Clin Lab Sci, 2002, 39(1) : 63288.
[ 16 ] 　van der PaardtM, Crusius JBA, GrMA, et al. Suscep tibility to ankylosing spondylitis: no evidence for the involvement of transforming growth factor β1 ( TGFβ1 ) gene polymorphisms [ J ]. AnnRheum Dis, 2005, 64 (4) : 6162619.
[ 17 ] 　Howe HS, Cheung PL, Kong KO, et al. Transforming growth factor beta21 and gene polymorphisms in oriental ankylosing spondylitis[ J ]. Rheumatology, 2005, 44 (1) : 51254.
[ 18 ] 　Jaakkola E, Crane AM, Laiho K, et al. The effect of transforming growth factor beta1 gene polymorphisms in ankylosing spondylitis[ J ]. Rheumatology, 2004, 43 (1) : 32238.
[ 19 ] 　Granfors K, Marker2Hermann E, de Keyser F, et al. The cutting edge of spondylarthropathy research in the millennium [ J ]. Arthritis Rheum, 2002, 46 (3) : 6062613.
[ 20 ] 　Yang C, Gu J, RihlM, et al. Serum levels ofmatrixmetallop roteinase 3 and macrophage colony2stimulating factor 1 correlate with disease activity in ankylosing spondylitis [ J ]. Arthritis Rheum,2004, 51 (5) : 6912699.
[ 21 ] 　Ribbens C,Andre B, Kaye O, et al. Synovial fluid matrix metallop roteinase23 levels are increased in inflammatory arthritideswhether erosive or not [ J ]. Rheumatology (Oxford ) , 2000, 39 ( 12 ) :135721365.
[ 22 ] 　J in L,Weisman M, Zhang G, et al. Lack of association of matrix metallop roteinase 3 (MMP3) genotypeswith ankylosing spondylitissuscep tibility and severity [ J ]. Rheumatology (Oxford) , 2005, 44(1) : 55260.